HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/22/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. NOW
7. GM
8. SMCI
9. IBM
10. EFX

Go back to HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
(NASDAQ: HCWB) Delayed: 3.35 -0.03 (0.89%)
Previous Close $3.38    52 Week High $ 
Open $3.35    52 Week Low $ 
Day High $3.59    P/E N/A 
Day Low $3.13    EPS $ 
Volume 89,789       

(NASDAQ: HCWB) Delayed: 3.35 -0.03 (0.89%)
Previous Close $3.38    52 Week High $ 
Open $3.35    52 Week Low $ 
Day High $3.59    P/E N/A 
Day Low $3.13    EPS $ 
Volume 89,789